DHR

+ Watchlist + Portfolio

Danaher Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $211.50
52-Week Range: $160.93 – $242.80
Market Cap: $151.78B
P/E (TTM): 37.75
EPS (TTM): 5.72
Dividend Yield: 0.76%

Advanced Metrics

Price/Book: 2.89
PEG Ratio: 1.38
Return on Equity: 7.61%
Return on Assets: 3.95%
Gross Margin: 58.75%
Operating Margin: 19.78%
Profit Margin: 15.95%
Current Ratio: 1.65
Debt/Equity: 0.53
Total Debt: $27.86B
Free Cash Flow: $4.33B
Revenue Growth: 5.50%
Earnings Growth: 59.70%
Enterprise Value: $175.30B

DHR Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$26.64B	$23.89B	$23.88B	$24.57B
Cost of Revenue	$10.46B	$9.86B	$9.67B	$10.04B
Gross Profit	$16.19B	$14.03B	$14.21B	$14.52B
Research & Development	$1.53B	$1.50B	$1.58B	$1.60B
Selling, General & Admin	$7.12B	$7.33B	$7.76B	$8.23B
Operating Expenses	$8.65B	$8.83B	$9.34B	$9.83B
Operating Income	$7.54B	$5.20B	$4.86B	$4.69B
EBITDA	$9.48B	$7.50B	$7.28B	$6.95B
Pretax Income	$7.15B	$5.04B	$4.65B	$4.23B
Income Tax	$818.00M	$823.00M	$747.00M	$633.00M
Net Income	$7.21B	$4.76B	$3.90B	$3.61B
Diluted EPS	9.66	6.38	5.29	5.05
Diluted Shares	737.10M	743.10M	737.20M	716.10M

DHR Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$6.00B	$5.86B	$2.08B	$4.62B
Receivables	$4.10B	$3.92B	$3.54B	$3.91B
Inventory	$2.77B	$2.59B	$2.33B	$2.49B
Current Assets	$15.88B	$13.94B	$9.50B	$12.76B
Total Assets	$84.35B	$84.49B	$77.54B	$83.46B
Current Liabilities	$8.39B	$8.27B	$6.80B	$6.81B
Long-Term Debt	$19.09B	$16.71B	$15.50B	$18.42B
Total Debt	$20.62B	$19.54B	$17.15B	$19.70B
Total Liabilities	$34.26B	$31.00B	$27.99B	$30.92B
Retained Earnings	$39.20B	$41.07B	$44.19B	$46.89B
Shareholders' Equity	$50.08B	$53.49B	$49.54B	$52.53B
Working Capital	$7.49B	$5.66B	$2.70B	$5.95B
Net Debt	$13.68B	$12.54B	$13.93B	$13.80B

DHR Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$8.52B	$7.16B	$6.69B	$6.42B
Capital Expenditure	-$1.12B	-$1.38B	-$1.39B	-$1.16B
Free Cash Flow	$7.40B	$5.78B	$5.30B	$5.26B
Depreciation & Amortisation	$2.13B	$2.17B	$2.35B	$2.45B
Stock-Based Compensation	$295.00M	$306.00M	$288.00M	$298.00M
Investing Cash Flow	-$2.23B	-$7.08B	-$1.98B	-$1.20B
Financing Cash Flow	-$2.57B	-$273.00M	-$8.38B	-$2.96B
Dividends Paid	-$818.00M	-$1.25B	-$768.00M	-$878.00M
Share Repurchases	$0.00	$0.00	-$5.98B	-$3.09B
Net Change in Cash	$3.71B	-$190.00M	-$3.68B	$2.26B

DHR Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$5.94B	$6.05B	$6.84B	$5.95B	$6.26B
Cost of Revenue	$2.41B	$2.53B	$2.87B	$2.36B	$2.65B
Gross Profit	$3.52B	$3.52B	$3.97B	$3.59B	$3.61B
Research & Development	$403.00M	$378.00M	$438.00M	$387.00M	$412.00M
Selling, General & Admin	$2.36B	$1.99B	$2.03B	$1.86B	$2.07B
Operating Expenses	$2.76B	$2.37B	$2.46B	$2.25B	$2.48B
Operating Income	$760.00M	$1.15B	$1.50B	$1.34B	$1.13B
EBITDA	$1.34B	$1.76B	$2.05B	$1.93B	$1.84B
Pretax Income	$655.00M	$1.08B	$1.37B	$1.24B	$1.08B
Income Tax	$100.00M	$168.00M	$190.00M	$206.00M	$208.00M
Net Income	$555.00M	$908.00M	$1.20B	$1.03B	$870.00M
Diluted EPS	0.77	1.27	1.68	1.45	1.23
Diluted Shares	719.10M	713.70M	711.00M	711.20M	707.60M

DHR Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$2.96B	$1.53B	$4.62B	$5.70B	$4.35B
Receivables	$3.56B	$3.75B	$3.91B	$3.82B	$3.96B
Inventory	$2.69B	$2.67B	$2.49B	$2.61B	$3.26B
Current Assets	$11.00B	$9.61B	$12.76B	$13.94B	$13.38B
Total Assets	$81.62B	$79.90B	$83.46B	$83.54B	$92.37B
Current Liabilities	$6.79B	$6.32B	$6.81B	$7.46B	$8.11B
Long-Term Debt	$16.85B	$16.83B	$18.42B	$17.56B	$25.15B
Total Debt	$17.36B	$16.86B	$19.70B	$18.48B	$26.56B
Total Liabilities	$29.28B	$28.82B	$30.92B	$30.59B	$39.77B
Retained Earnings	$45.24B	$45.92B	$46.89B	$47.64B	$48.23B
Shareholders' Equity	$52.33B	$51.07B	$52.53B	$52.95B	$52.58B
Working Capital	$4.21B	$3.28B	$5.95B	$6.47B	$5.28B
Net Debt	$14.40B	$15.33B	$13.80B	$12.78B	$22.21B

DHR Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$1.34B	$1.66B	$2.12B	$1.32B	$1.53B
Capital Expenditure	-$248.00M	-$292.00M	-$371.00M	-$237.00M	-$269.00M
Free Cash Flow	$1.09B	$1.37B	$1.75B	$1.08B	$1.26B
Depreciation & Amortisation	$611.00M	$622.00M	$623.00M	$627.00M	$659.00M
Stock-Based Compensation	$91.00M	$83.00M	$63.00M	$58.00M	$93.00M
Investing Cash Flow	-$258.00M	-$312.00M	-$384.00M	-$249.00M	-$10.15B
Financing Cash Flow	-$247.00M	-$2.78B	$1.32B	$46.00M	$7.27B
Dividends Paid	-$229.00M	-$229.00M	-$226.00M	-$226.00M	-$283.00M
Share Repurchases	$0.00	-$2.01B	$0.00	$0.00	-$894.00M
Net Change in Cash	$833.00M	-$1.43B	$3.06B	$1.12B	-$1.34B

Market Snapshot

About

Danaher Corp. is a diversified science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through three primary segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Danaher's portfolio includes leading brands in biotechnology tools, clinical diagnostics, water quality analysis, and product identification. The company is known for its Danaher Business System, a management approach focused on continuous improvement and lean manufacturing principles. Danaher has a strong track record of acquiring and integrating businesses to expand its technology platform and global market presence.